Damage Control Resuscitation for Catastrophic Bleeding

Oral and Maxillofacial Surgery Clinics of North America

Volumn 28, Issue 4, 2016, Pages 553-568

  Andreason, Chase L ^a   Pohlman, Timothy H ^b  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Coagulopathy; Hemorrhage; Resuscitation; Shock; Thrombelastography; Transfusion

Indexed keywords

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT THERAPY; COMPLICATION; FACIAL INJURIES; HEMOSTASIS; HUMAN; ORAL SURGERY; PROCEDURES; RESUSCITATION; SHOCK, HEMORRHAGIC;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; FACIAL INJURIES; HEMOSTASIS, SURGICAL; HUMANS; ORAL SURGICAL PROCEDURES; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 84995467867     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2016.06.010     Document Type: Review

References (149)

1. 1 Schochl, H., Grassetto, A., Schlimp, C.J., Management of hemorrhage in trauma. J Cardiothorac Vasc Anesth 27 (2013), S35–S43.
2. 2 Weiskopf, R.B., Ness, P.M., Transfusion for remote damage control resuscitation. Transfusion 53:Suppl 1 (2013), 1S–5S.
3. 3 Ball, C.G., Damage control resuscitation: history, theory and technique. Can J Surg 57 (2014), 55–60.
4. 4 Gonzalez, E., Moore, E.E., Moore, H.B., et al. Trauma-induced coagulopathy: an institution's 35 year perspective on practice and research. Scand J Surg 103 (2014), 89–103.
5. 5 Jenkins, D.H., Rappold, J.F., Badloe, J.F., et al. Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps. Shock 41:Suppl 1 (2014), 3–12.
6. 6 Johansson, P.I., Stensballe, J., Oliveri, R., et al. How I treat patients with massive hemorrhage. Blood 124:20 (2014), 3052–3058.
7. 7 Pohlman, T.H., Walsh, M., Aversa, J., et al. Damage control resuscitation. Blood Rev 29 (2015), 251–262.
8. 8 Cotton, B.A., Au, B.K., Nunez, T.C., et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 66 (2009), 41–48.
9. 9 Cotton, B.A., Reddy, N., Hatch, Q.M., et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 254 (2011), 598–605.
10. 10 Roback, J.D., Caldwell, S., Carson, J., et al. American Association for the Study of Liver American Academy of Pediatrics United States Army, American Society of Anesthesiology; American Society of Hematology. Evidence-based practice guidelines for plasma transfusion. Transfusion 50 (2010), 1227–1239.
11. 11 Cryer, H.G., Nathens, A.B., Bulger, E.M., et al. ACS TQIP massive transfusion in trauma guidelines. ACS Trauma Quality Improvement Program, vol. 2015, 2013, American College of Surgeons Committee on Trauma, Chicago, Il.
12. 12 Wiegmann, T.L., Mintz, P.D., The growing role of AABB clinical practice guidelines in improving patient care. Transfusion 55 (2015), 935–936.
13. 13 Mutschler, M., Nienaber, U., Brockamp, T., et al., TraumaRegister DGU. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU(R). Crit Care, 17, 2013, R42.
14. 14 Shere-Wolfe, R.F., Galvagno, S.M. Jr., Grissom, T.E., Critical care considerations in the management of the trauma patient following initial resuscitation. Scand J Trauma Resusc Emerg Med, 20, 2012, 68.
15. 15 Gann, D.S., Drucker, W.R., Hemorrhagic shock. J Trauma Acute Care Surg 75 (2013), 888–895.
16. 16 Orlinsky, M., Shoemaker, W., Reis, E.D., et al. Current controversies in shock and resuscitation. Surg Clin North Am 81 (2001), 1217–1262.
17. 17 Guan, J., Jin, D.D., Jin, L.J., et al. Apoptosis in organs of rats in early stage after polytrauma combined with shock. J Trauma 52 (2002), 104–111.
18. 18 Cowley, R.A., Mergner, W.J., Fisher, R.S., et al. The subcellular pathology of shock in trauma patients: studies using the immediate autopsy. Am Surg 45 (1979), 255–269.
19. 19 Dunser, M.W., Takala, J., Brunauer, A., et al. Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach. Crit Care, 17, 2013, 326.
20. 20 Guly, H.R., Bouamra, O., Spiers, M., et al. Vital signs and estimated blood loss in patients with major trauma: testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation 82 (2011), 556–559.
21. 21 Strehlow, M.C., Early identification of shock in critically ill patients. Emerg Med Clin North Am 28 (2010), 57–66.
22. 22 Vandromme, M.J., Griffin, R.L., Weinberg, J.A., et al. Lactate is a better predictor than systolic blood pressure for determining blood requirement and mortality: could prehospital measures improve trauma triage?. J Am Coll Surg 210 (2010), 861–867 867–9.
23. 23 Wilson, M., Davis, D.P., Coimbra, R., Diagnosis and monitoring of hemorrhagic shock during the initial resuscitation of multiple trauma patients: a review. J Emerg Med 24 (2003), 413–422.
24. 24 Brasel, K.J., Guse, C., Gentilello, L.M., et al. Heart rate: is it truly a vital sign?. J Trauma 62 (2007), 812–817.
25. 25 Cannon, C.M., Braxton, C.C., Kling-Smith, M., et al. Utility of the shock index in predicting mortality in traumatically injured patients. J Trauma 67 (2009), 1426–1430.
26. 26 Little, R.A., Kirkman, E., Driscoll, P., et al. Preventable deaths after injury: why are the traditional 'vital' signs poor indicators of blood loss?. J Accid Emerg Med 12 (1995), 1–14.
27. 27 Vandromme, M.J., Griffin, R.L., Kerby, J.D., et al. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma 70 (2011), 384–388.
28. 28 Zarzaur, B.L., Croce, M.A., Fischer, P.E., et al. New vitals after injury: shock index for the young and age x shock index for the old. J Surg Res 147 (2008), 229–236.
29. 29 Zarzaur, B.L., Croce, M.A., Magnotti, L.J., et al. Identifying life-threatening shock in the older injured patient: an analysis of the National Trauma Data Bank. J Trauma 68 (2010), 1134–1138.
30. 30 Mitra, B., Fitzgerald, M., Chan, J., The utility of a shock index >/= 1 as an indication for pre-hospital oxygen carrier administration in major trauma. Injury 45 (2014), 61–65.
31. 31 Ardagh, M.W., Hodgson, T., Shaw, L., et al. Pulse rate over pressure evaluation (ROPE) is useful in the assessment of compensated haemorrhagic shock. Emerg Med (Fremantle) 13 (2001), 43–46.
32. 32 Campbell, R., Ardagh, M.W., Than, M., Validation of the pulse rate over pressure evaluation index as a detector of early occult hemorrhage: a prospective observational study. J Trauma Acute Care Surg 73 (2012), 286–288.
33. 33 Juern, J., Khatri, V., Weigelt, J., Base excess: a review. J Trauma Acute Care Surg 73 (2012), 27–32.
34. 34 Dunham, C.M., Watson, L.A., Cooper, C., Base deficit level indicating major injury is increased with ethanol. J Emerg Med 18 (2000), 165–171.
35. 35 Cardenas, J.C., Wade, C.E., Holcomb, J.B., Mechanisms of trauma-induced coagulopathy. Curr Opin Hematol 21 (2014), 404–409.
36. 36 Davenport, R.A., Brohi, K., Cause of trauma-induced coagulopathy. Curr Opin Anaesthesiol 29 (2016), 212–219.
37. 37 Noel, P., Cashen, S., Patel, B., Trauma-Induced Coagulopathy: From Biology to Therapy. Semin Hematol 50 (2013), 259–269.
38. 38 MacLeod, J.B., Lynn, M., McKenney, M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 55 (2003), 39–44.
39. 39 Brohi, K., Cohen, M.J., Ganter, M.T., et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 64 (2008), 1211–1217.
40. 40 Cohen, M.J., Kutcher, M., Redick, B., et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg 75 (2013), S40–S47.
41. 41 Haywood-Watson, R.J., Holcomb, J.B., Gonzalez, E.A., et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One, 6, 2011, e23530.
42. 42 Johansson, P.I., SØRensen, A.M., Perner, A., et al. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost 10 (2012), 207–216.
43. 43 Johansson, P.I., Stensballe, J., Rasmussen, L.S., et al. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 72 (2012), 428–436.
44. 44 Mann, K.G., Freeman, K., TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy. J Thromb Haemost 13:Suppl 1 (2015), S63–S71.
45. 45 Martin, F.A., Murphy, R.P., Cummins, P.M., Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol 304 (2013), H1585–H1597.
46. 46 Gando, S., Otomo, Y., Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care, 19, 2015, 72.
47. 47 Becker, B.F., Chappell, D., Bruegger, D., et al. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 87 (2010), 300–310.
48. 48 Ostrowski, S.R., Johansson, P.I., Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 73 (2012), 60–66.
49. 49 Castellino, F.J., Chapman, M.P., Donahue, D.L., et al. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. J Trauma Acute Care Surg 76 (2014), 1169–1176.
50. 50 Ramsey, M.T., Fabian, T.C., Shahan, C.P., et al. A prospective study of platelet function in trauma patients. J Trauma Acute Care Surg 80:5 (2016), 726–733.
51. 51 Johansson, P.I., Sorensen, A.M., Perner, A., et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care, 15, 2011, R272.
52. 52 Gando, S., Wada, H., Kim, H.K., et al. Scientific, Standardization Committee on DICotI. Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma-shock. J Thromb Haemost 10 (2012), 2593–2595.
53. 53 Schochl, H., Voelckel, W., Maegele, M., et al. Trauma-associated hyperfibrinolysis. Hamostaseologie 32 (2012), 22–27.
54. 54 Okafor, O.N., Gorog, D.A., Endogenous fibrinolysis: an important mediator of thrombus formation and cardiovascular risk. J Am Coll Cardiol 65 (2015), 1683–1699.
55. 55 Schuster, V., Hugle, B., Tefs, K., Plasminogen deficiency. J Thromb Haemost 5 (2007), 2315–2322.
56. 56 Mehta, R., Shapiro, A.D., Plasminogen deficiency. Haemophilia 14 (2008), 1261–1268.
57. 57 Raza, I., Davenport, R., Rourke, C., et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 11 (2013), 307–314.
58. 58 Bolliger, D., Szlam, F., Levy, J.H., et al. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 104 (2010), 318–325.
59. 59 Moore, E.E., Moore, H.B., Gonzalez, E., et al. Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid. J Trauma Acute Care Surg 78 (2015), S65–S69.
60. 60 Chapman, M.P., Moore, E.E., Moore, H.B., et al. The “Black Diamond”: rapid thrombelastography identifies lethal hyperfibrinolysis. J Trauma Acute Care Surg 79:6 (2015), 925–929.
61. 61 Hunt, B.J., Segal, H., Hyperfibrinolysis. J Clin Pathol, 49, 1996, 958.
62. 62 Stachurska, J., Latallo, Z., Kopec, M., Inhibition of platelet aggregation by dialysable fibrinogen degradation products (FDP). Thromb Diath Haemorrh 23 (1970), 91–98.
63. 63 vanDeWater, L., Carr, J.M., Aronson, D., et al. Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease. Blood 67 (1986), 1468–1473.
64. 64 Khan, S., Allard, S., Weaver, A., et al. A major haemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion. Injury 44 (2013), 587–592.
65. 65 Holcomb, J.B., Gumbert, S., Potential value of protocols in substantially bleeding trauma patients. Curr Opin Anaesthesiol 26 (2013), 215–220.
66. 66 Lubarsky, D.A., Smith, L.R., Sladen, R.N., et al. Defining the relationship of oxygen delivery and consumption: use of biologic system models. J Surg Res 58 (1995), 503–508.
67. 67 Omert, L.A., Billiar, T.R., Hemorrhagic shock: from physiology to molecular biology. Pinski, M., (eds.) Applied cardiovascular physiology, Vol 28, 1997, Springer, Berlin, 209–216.
68. 68 D'Alessandro, A., Kriebardis, A.G., Rinalducci, S., et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 55 (2015), 205–219.
69. 69 Zubair, A.C., Clinical impact of blood storage lesions. Am J Hematol 85 (2010), 117–122.
70. 70 Kim-Shapiro, D.B., Lee, J., Gladwin, M.T., Storage lesion: role of red blood cell breakdown. Transfusion 51 (2011), 844–851.
71. 71 Tinmouth, A., Fergusson, D., Yee, I.C., et al., Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 46 (2006), 2014–2027.
72. 72 Almac, E., Bezemer, R., Hilarius-Stokman, P.M., et al. Red blood cell storage increases hypoxia-induced nitric oxide bioavailability and methemoglobin formation in vitro and in vivo. Transfusion 54 (2014), 3178–3185.
73. 73 Young, J.A., Lichtman, M.A., Cohen, J., Reduced red cell 2,3-diphosphoglycerate and adenosine triphosphate, hypophosphatemia, and increased hemoglobin-oxygen affinity after cardiac surgery. Circulation 47 (1973), 1313–1318.
74. 74 Watkins, G.M., Rabelo, A., Pizak, L.F., et al. The left shifted oxyhemoglobin curve in sepsis: a preventable defect. Ann Surg 180 (1974), 213–220.
75. 75 Raat, N.J.H., Ince, C., Oxygenating the microcirculation: the perspective from blood transfusion and blood storage. Vox Sang 93 (2007), 12–18.
76. 76 Middelburg, R.A., Borkent, B., Jansen, M., et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 52 (2012), 658–667.
77. 77 Hampton, D.A., Wiles, C., Fabricant, L.J., et al. Cryopreserved red blood cells are superior to standard liquid red blood cells. J Trauma Acute Care Surg 77 (2014), 20–27.
78. 78 Johansson, P.I., Hansen, M.B., Sorensen, H., Transfusion practice in massively bleeding patients: time for a change?. Vox Sang 89 (2005), 92–96.
79. 79 Cushing, M., Shaz, B.H., Blood transfusion in trauma patients: unresolved questions. Minerva Anestesiol 77 (2011), 349–359.
80. 80 Gutierrez, M.C., Goodnough, L.T., Druzin, M., et al. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth 21 (2012), 230–235.
81. 81 Holcomb, J.B., Pati, S., Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program 2013 (2013), 656–659.
82. 82 Holcomb, J.B., Wade, C.E., Michalek, J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 248 (2008), 447–458.
83. 83 Johansson, P.I., Stensballe, J., Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 96 (2009), 111–118.
84. 84 Johansson, P.I., Stensballe, J., Ostrowski, S.R., Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med, 20, 2012, 47.
85. 85 Riskin, D.J., Tsai, T.C., Riskin, L., et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 209 (2009), 198–205.
86. 86 Holcomb, J.B., Optimal use of blood products in severely injured trauma patients. Hematology Am Soc Hematol Educ Program 2010 (2010), 465–469.
87. 87 Holcomb, J.B., Tilley, B.C., Baraniuk, S., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313 (2015), 471–482.
88. 88 Hess, J.R., Holcomb, J.B., Resuscitating PROPPRly. Transfusion 55:6 (2015), 1362–1364.
89. 89 Buchta, C., Felfernig, M., Hocker, P., et al. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Vox Sang 87 (2004), 182–186.
90. 90 Chhibber, V., Greene, M., Vauthrin, M., et al. Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME). Transfusion 54 (2014), 1751–1755.
91. 91 Cooling, L., Going from A to B: the safety of incompatible group A plasma for emergency release in trauma and massive transfusion patients. Transfusion 54 (2014), 1695–1697.
92. 92 Mehr, C.R., Gupta, R., von Recklinghausen, F.M., et al. Balancing risk and benefit: maintenance of a thawed Group A plasma inventory for trauma patients requiring massive transfusion. J Trauma Acute Care Surg 74 (2013), 1425–1431.
93. 93 Zielinski, M.D., Johnson, P.M., Jenkins, D., et al. Emergency use of prethawed Group A plasma in trauma patients. J Trauma Acute Care Surg 74 (2013), 69–74.
94. 94 Levy, J.H., Szlam, F., Tanaka, K.A., et al. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 114 (2012), 261–274.
95. 95 Meyer, M.A., Ostrowski, S.R., Sorensen, A.M., et al. Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assays. J Surg Res 194 (2015), 581–590.
96. 96 Rourke, C., Curry, N., Khan, S., et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 10 (2012), 1342–1351.
97. 97 Kushimoto, S., Shibata, Y., Yamamoto, Y., Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 20 (2003), 357–363.
98. 98 Martini, W.Z., Holcomb, J.B., Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 246 (2007), 831–835.
99. 99 Johansson, P.I., Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 25 (2012), 235–241.
100. 100 Bolliger, D., Seeberger, M.D., Tanaka, K.A., Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 26 (2012), 1–13.
101. 101 Rumph, B., Bolliger, D., Narang, N., et al. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. J Cardiothorac Vasc Anesth 24 (2010), 408–412.
102. 102 Johansson, P.I., Goal-directed hemostatic resuscitation for massively bleeding patients: the Copenhagen concept. Transfus Apher Sci 43 (2010), 401–405.
103. 103 da Luz, L.T., Nascimento, B., Rizoli, S., Thrombelastography (TEG(R)): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med, 21, 2013, 29.
104. 104 Jeger, V., Zimmermann, H., Exadaktylos, A.K., Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries?. J Trauma 66 (2009), 1253–1257.
105. 105 Genet, G.F., Ostrowski, S.R., Sorensen, A.M., et al. Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 18 (2012), 638–644.
106. 106 Kashuk, J.L., Moore, E.E., Wohlauer, M., et al. Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion 52 (2012), 23–33.
107. 107 Kashuk, J.L., Moore, E.E., Sawyer, M., et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg 251 (2010), 604–614.
108. 108 Gorlinger, K., Dirkmann, D., Hanke, A.A., Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol 26 (2013), 230–243.
109. 109 Napolitano, L.M., Cohen, M.J., Cotton, B.A., et al. Tranexamic acid in trauma: how should we use it?. J Trauma Acute Care Surg 74 (2013), 1575–1586.
110. 110 Shakur, H., Roberts, I., Bautista, R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376 (2010), 23–32.
111. 111 Binz, S., McCollester, J., Thomas, S., et al. CRASH-2 study of tranexamic acid to treat bleeding in trauma patients: a controversy fueled by science and social media. J Blood Transfus, 2015, 2015, 874920.
112. 112 Schochl, H., Nienaber, U., Maegele, M., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care, 15, 2011, R83.
113. 113 Harr, J.N., Moore, E.E., Ghasabyan, A., et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 39 (2013), 45–49.
114. 114 Bonfanti, C., Crestani, S., Frattini, F., et al. Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature. Blood Transfus 13 (2015), 396–400.
115. 115 Schotola, H., Sossalla, S., Rajab, T.K., et al. Influence of mild metabolic acidosis on cardiac contractility and isoprenaline response in isolated ovine myocardium. Artif Organs 35 (2011), 1065–1074.
116. 116 Kraut, J.A., Madias, N.E., Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 6 (2010), 274–285.
117. 117 Kraut, J.A., Madias, N.E., Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 8 (2012), 589–601.
118. 118 Martini, W.Z., Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma 67 (2009), 202–208.
119. 119 Murthi, S.B., Stansbury, L.G., Dutton, R.P., et al. Transfusion medicine in trauma patients: an update. Expert Rev Hematol 4 (2011), 527–537.
120. 120 Tremblay, L.N., Feliciano, D.V., Rozycki, G.S., Assessment of initial base deficit as a predictor of outcome: mechanism of injury does make a difference. Am Surg 68 (2002), 689–693.
121. 121 Nahas, G.G., Sutin, K.M., Fermon, C., et al. Guidelines for the treatment of acidaemia with THAM. Drugs 55 (1998), 191–224.
122. 122 Wolberg, A.S., Meng, Z.H., Monroe, D.M. 3rd, et al. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56 (2004), 1221–1228.
123. 123 Kermode, J.C., Zheng, Q., Milner, E.P., Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94 (1999), 199–207.
124. 124 Douning, L.K., Ramsay, M.A., Swygert, T.H., et al. Temperature corrected thrombelastography in hypothermic patients. Anesth Analg 81 (1995), 608–611.
125. 125 Martini, W.Z., Cortez, D.S., Dubick, M.A., et al. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 65 (2008), 535–543.
126. 126 Peng, R.Y., Bongard, F.S., Hypothermia in trauma patients. J Am Coll Surg 188 (1999), 685–696.
127. 127 Okada, M., The cardiac rhythm in accidental hypothermia. J Electrocardiol 17 (1984), 123–128.
128. 128 Gentilello, L.M., Moujaes, S., Treatment of hypothermia in trauma victims: thermodynamic considerations. J Intensive Care Med 10 (1995), 5–14.
129. 129 Sihler, K.C., Napolitano, L.M., Complications of massive transfusion. Chest 137 (2010), 209–220.
130. 130 Passman, R., Kadish, A., Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 85 (2001), 321–341.
131. 131 Moore, F.A., Moore, E.E., Sauaia, A., Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132 (1997), 620–624.
132. 132 Toy, P., Gajic, O., Bacchetti, P., et al., TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood 119 (2012), 1757–1767.
133. 133 FDA Center for Biologics Evaluation and Research. Fatalities reported to the FDA following blood collection and transfusion. Annual Summary for Fiscal Year 2014. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM459461.pdf. Accessed July 18, 2016.
134. 134 Palfi, M., Berg, S., Ernerudh, J., et al. A randomized controlled trial oftransfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?. Transfusion 41 (2001), 317–322.
135. 135 Murphy, E.L., Kwaan, N., Looney, M.R., et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 126:357 (2013), e29–e38.
136. 136 Conway, E.M., Thrombomodulin and its role in inflammation. Semin Immunopathol 34 (2012), 107–125.
137. 137 Niesler, U., Palmer, A., Froba, J.S., et al. Role of alveolar macrophages in the regulation of local and systemic inflammation after lung contusion. J Trauma Acute Care Surg 76 (2014), 386–393.
138. 138 Neal, M.D., Raval, J.S., Triulzi, D.J., et al. Innate immune activation after transfusion of stored red blood cells. Transfus Med Rev 27 (2013), 113–118.
139. 139 Bae, J.S., Rezaie, A.R., Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118 (2011), 3952–3959.
140. 140 Treutiger, C.J., Mullins, G.E., Johansson, A.S., et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 254 (2003), 375–385.
141. 141 McGhan, L.J., Jaroszewski, D.E., The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury 43 (2012), 129–136.
142. 142 Prince, J.M., Levy, R.M., Yang, R., et al. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202 (2006), 407–417.
143. 143 Cheatham, M.L., Malbrain, M.L., Cardiovascular implications of abdominal compartment syndrome. Acta Clin Belg 62:Suppl 1 (2007), 98–112.
144. 144 Fabian, T.C., Damage control in trauma: laparotomy wound management acute to chronic. Surg Clin North Am 87 (2007), 73–93.
145. 145 Cheatham, M.L., Abdominal compartment syndrome. Curr Opin Crit Care 15 (2009), 154–162.
146. 146 Barnes, G.E., Laine, G.A., Giam, P.Y., et al. Cardiovascular responses to elevation of intra-abdominal hydrostatic pressure. Am J Physiol 248 (1985), R208–R213.
147. 147 Cullen, D.J., Coyle, J.P., Teplick, R., et al. Cardiovascular, pulmonary, and renal effects of massively increased intra-abdominal pressure in critically ill patients. Crit Care Med 17 (1989), 118–121.
148. 148 Cheatham, M.L., Nelson, L.D., Chang, M.C., et al. Right ventricular end-diastolic volume index as a predictor of preload status in patients on positive end-expiratory pressure. Crit Care Med 26 (1998), 1801–1806.
149. 149 Kobayashi, L., Costantini, T.W., Coimbra, R., Hypovolemic shock resuscitation. Surg Clin North Am 92 (2012), 1403–1423.